Lataa...
Prolonged use of bedaquiline in two patients with pulmonary extensively drug-resistant tuberculosis: Two case reports
BACKGROUND: Bedaquiline is among the prioritized drugs recommended by the World Health Organization for the treatment of extensively drug-resistant tuberculosis (XDR-TB). Many patients have not achieved better clinical improvement after bedaquiline is stopped at 24 wk. However, there is no recommend...
Tallennettuna:
| Julkaisussa: | World J Clin Cases |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8026830/ https://ncbi.nlm.nih.gov/pubmed/33869610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v9.i10.2326 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|